Van Plew Daniel P

Van Plew Daniel P is listed in filings as EVP & General Mgr at Regeneron Pharmaceuticals Inc. This profile follows SEC Form 4 activity through Dec 11, 2025, including 8 public disclosures. Recent filings connect the profile to Regeneron Pharmaceuticals Inc (REGN). The current snapshot covers public activity from Dec 10, 2024 to Dec 11, 2025. Reported amounts are shown as $10.4M to $708.2K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.